Eurofins Technologies’ Range of Testing Kits for Serology-based Antibody Detection by ELISA in Patients Exposed to COVID-19 now Available to Order Online by Government Approved Clinical Laboratories ...
SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional ...
OMAHA, Neb. & GLASGOW, United Kingdom--(BUSINESS WIRE)--ADS Biotec, a global leader in development of automated instruments and consumables for use in cytogenetic, pathology and research laboratories ...
A new, 3D-printed, lab-on-chip system combines eRapid and SHERLOCK technologies into a single, postcard-sized system that can simultaneously detect the presence of both SARS-CoV-2 RNA and antibodies ...
GenScript USA Inc. – a subsidiary of GenScript Biotech Corp. headquartered in Piscataway – announced May 26 it reached an agreement with Euroimmun US Inc. – a Euroimmun subsidiary based in Mountain ...
The U.S. FDA has granted emergency use authorization (EUA) to Genscript USA Inc. for its Cpass SARS-CoV-2 Neutralization Antibody Detection Kit, the first commercially available test to detect ...
Using a multiplex and high throughput serological assay to achieve a thorough profile of antibodies against SARS-CoV-2 enables researchers to advance their research on COVID-19. Due to constant ...
LUXEMBOURG--(BUSINESS WIRE)-- In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a first range of testing kits for serology-based antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback